Citigroup Inc Cti Biopharma Corp Transaction History

Citigroup Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	BUY	$4.2 - $6.01 $1.11 Million - $1.59 Million	263,892 Added 41.1%	906,013 $3.81 Million
Q4 2022 Feb 09, 2023	SELL	$4.45 - $6.17 $1.55 Million - $2.14 Million	-347,325 Reduced 35.1%	642,121 $3.86 Million
Q3 2022 Nov 10, 2022	BUY	$5.36 - $7.43 $2.94 Million - $4.07 Million	547,603 Added 123.94%	989,446 $5.76 Million
Q2 2022 Aug 10, 2022	BUY	$3.55 - $6.27 $1.28 Million - $2.25 Million	359,425 Added 436.1%	441,843 $2.64 Million
Q1 2022 May 12, 2022	BUY	$1.9 - $5.23 $156,594 - $431,046	82,418 New	82,418 $385,000

Ticker CTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,385,000
Market Cap $1.04B
Description
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.